Product Type
Bath & Body
Condition
New
Retatrutide is a novel triple-hormone receptor agonist, targeting GIP, GLP-1, and glucagon receptors. Its primary benefit is exceptional weight loss efficacy, with clinical trials showing over 24% average reduction, surpassing current GLP-1 medications. This triple action enhances metabolic control, significantly improving blood sugar, insulin sensitivity, and cholesterol levels. It addresses obesity as a root cause of conditions like type 2 diabetes and cardiovascular disease, offering a powerful therapeutic tool for substantial and sustained weight management with improved cardiometabolic health, positioning it as a potential breakthrough in obesity treatment.